Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

KLTO 101

Next Previous
Drug Profile

KLTO 101

Alternative Names: AAV9.CMV.s-KL; KLTO-101

Latest Information Update: 28 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Klotho Neurosciences
  • Developer Klotho Neurosciences; Unknown
  • Class Gene therapies; Neuroprotectants
  • Mechanism of Action Gene transference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Alzheimer's disease; Dementia; Huntington's disease; Spinal cord injuries; Stroke

Highest Development Phases

  • Preclinical Alzheimer's disease; Dementia; Huntington's disease; Parkinson's disease; Spinal cord injuries; Stroke

Most Recent Events

  • 25 Feb 2025 Klotho Neurosciences plans to initiate a phase II/III trial for rare disease in 2028
  • 25 Feb 2025 Unknown company plans to initiate a phase II/III trial for Alzheimer's disease in 2028
  • 08 Jan 2025 KLTO 101 is available for licensing as of 08 Jan 2025. https://klothoneuro.com/

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top